Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer

journal contribution

posted on 2024-06-03, 17:52 authored by M Nakhjavani, Sarah ShigdarSarah Shigdar

Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1016/j.phrs.2021.106019

Location

Amsterdam, The Netherlands

Language

eng

Author URL

https://www.ncbi.nlm.nih.gov/pubmed/34861397

Publication classification

C1 Refereed article in a scholarly journal

Journal

Pharmacological Research

Volume

175

Article number

106019

Pagination

1-11

ISSN

1043-6618

eISSN

1096-1186

Publisher

Elsevier

Usage metrics

Categories

Pharmacology and pharmaceutical sciences not elsewhere classified

Keywords

Aptamer Immunotherapy Monoclonal antibody PD-1 PD-L1 Triple-negative breast cancer 3214 Pharmacology and pharmaceutical sciences 3204 Immunology

Licence

All Rights Reserved

Exports